Higher susceptibility of spontaneous and NNK‐induced lung neoplasms in connexin 43 deficient CD1 × AJ F1 mice: Paradoxical expression of connexin 43 during lung carcinogenesis

Connexins (Cxs) are proteins that form the communicating gap junctions, and reportedly have a role in carcinogenesis. Here, we evaluated the importance of Connexin43 (Cx43) in spontaneous and 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK)‐induced lung carcinogenesis. Male wild‐type (Cx43+/+) and hemizygote (Cx43+/−) CD1 × AJ F1 mice were injected with NNK or saline. After 60 weeks mice were euthanized; lung nodules were counted, measured, and fixed in formalin or snap frozen. Immunohistochemistry for Cx43 and Beta‐catenin (β‐catenin) was performed and Cx43 mRNA expression was evaluated by real‐time PCR. Cx43 deletion significantly increased the incidence and number of spontaneous nodules in the CD1 × AJ F1 mice and the number of gross lesions and the aggressiveness of lesions in NNK‐treated mice. Cx43 mRNA increased significantly and was correlated with the aggressiveness of tumors, although lesions from Cx43+/− mice expressed less Cx43 RNAm than their counterparts. Lung parenchyma presented a Cx43 immunostaining pattern with points or plaques between cells. In hyperplasias and adenomas, Cx43 was found in the membrane and in cytoplasm. Malignant lesions presented increased Cx43 in cytoplasm and a few membrane spots of immunostaining. β‐catenin was weakly expressed in lung parenchyma. Though hyperplasias presented some cells with nuclear β‐catenin, NNK‐induced tumors contained a higher number of this staining pattern. Also, no difference in β‐catenin occurred between both genotypes independently of the histological grade. In summary, our results indicate that Cx43 acts as a tumor suppressor gene in early lung tumorigenesis and loses this property in advanced carcinogenesis. Therefore, Cxs are better classified as conditional tumor suppressors. © 2012 Wiley Periodicals, Inc.

[1]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[2]  C. Lee,et al.  Aberrant Wnt1/&bgr;-Catenin Expression is an Independent Poor Prognostic Marker of Non-small Cell Lung Cancer After Surgery , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  C. Naus,et al.  Implications and challenges of connexin connections to cancer , 2010, Nature Reviews Cancer.

[4]  H. Jiang,et al.  Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth , 2009, Cancer Gene Therapy.

[5]  M. Mesnil,et al.  Gap junctions and cancer: new functions for an old story. , 2009, Antioxidants & redox signaling.

[6]  J. Rey-Campos,et al.  Biological effects of FoxJ2 over-expression , 2008, Transgenic Research.

[7]  K. Willecke,et al.  Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium , 2008, BMC medicine.

[8]  A. Moorman,et al.  Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43. , 2008, Cardiovascular research.

[9]  B. Mayr,et al.  bZIP-Type transcription factors CREB and OASIS bind and stimulate the promoter of the mammalian transcription factor GCMa/Gcm1 in trophoblast cells , 2008, Nucleic acids research.

[10]  I. Morita,et al.  Vitamin K2 suppresses malignancy of HuH7 hepatoma cells via inhibition of connexin 43. , 2008, Cancer letters.

[11]  J. Hervé,et al.  Aberrant expression and localization of connexin43 and connexin30 in a rat glioma cell line , 2008, Molecular carcinogenesis.

[12]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[13]  A. Ben-Ze'ev,et al.  β‐Catenin signaling in biological control and cancer , 2007 .

[14]  Qing Shao,et al.  Connexins and Gap Junctions in Mammary Gland Development and Breast Cancer Progression , 2007, Journal of Membrane Biology.

[15]  T. Yoshioka,et al.  Pathological Significance of Intracytoplasmic Connexin Proteins: Implication in Tumor Progression , 2007, Journal of Membrane Biology.

[16]  F. Hernandez-Blazquez,et al.  Roles of Gap Junctions and Connexins in Non-Neoplastic Pathological Processes in which Cell Proliferation Is Involved , 2007, Journal of Membrane Biology.

[17]  I. Morita,et al.  Connexin 43 expression promotes malignancy of HuH7 hepatocellular carcinoma cells via the inhibition of cell-cell communication. , 2007, Cancer letters.

[18]  H. Fukumasu,et al.  Deletion of a single allele of Cx43 is associated with a reduction in the gap junctional intercellular communication and increased cell proliferation of mouse lung pneumocytes type II , 2007, Cell proliferation.

[19]  Y. Miyagi,et al.  Connexin expression in mouse lung tumor. , 2007, Cancer letters.

[20]  H. Yamasaki,et al.  Altered expression of connexins in urethane-induced mouse lung adenomas. , 2006, Life sciences.

[21]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Mesnil,et al.  Defective gap junctional intercellular communication in the carcinogenic process. , 2005, Biochimica et biophysica acta.

[23]  A. R. Thitoff,et al.  Beta-catenin regulates differentiation of respiratory epithelial cells in vivo. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[24]  T. Shirai,et al.  Transgenic Disruption of Gap Junctional Intercellular Communication Enhances Early but Not Late Stage Hepatocarcinogenesis in the Rat , 2005, Toxicologic pathology.

[25]  K. Warner The role of research in international tobacco control. , 2005, American journal of public health.

[26]  Biao He,et al.  Wnt signaling in lung cancer. , 2005, Cancer letters.

[27]  Anthony J Alberg,et al.  Epidemiology of lung cancer: looking to the future. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Jennifer A. Mitchell,et al.  Differential activation of the connexin 43 promoter by dimers of activator protein-1 transcription factors in myometrial cells. , 2005, Endocrinology.

[29]  P. Lampe,et al.  The Gap Junction Protein Connexin32 Is a Mouse Lung Tumor Suppressor , 2004, Cancer Research.

[30]  H. Yamasaki,et al.  Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. , 2004, Carcinogenesis.

[31]  Ajamete Kaykas,et al.  WNT and β-catenin signalling: diseases and therapies , 2004, Nature Reviews Genetics.

[32]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[33]  P. Lampe,et al.  Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation. , 2004, Carcinogenesis.

[34]  R. Cardiff,et al.  Classification of Proliferative Pulmonary Lesions of the Mouse , 2004, Cancer Research.

[35]  Stephen S. Hecht,et al.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer , 2003, Nature Reviews Cancer.

[36]  Ya‐Wen Cheng,et al.  The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  Roger A. Jones,et al.  K-ras gene sequence effects on the formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-DNA adducts. , 2003, Chemical research in toxicology.

[38]  Wei Zhang,et al.  Communication between malignant glioma cells and vascular endothelial cells through gap junctions. , 2003, Journal of neurosurgery.

[39]  J. Degen,et al.  Structural and Functional Diversity of Connexin Genes in the Mouse and Human Genome , 2002, Biological chemistry.

[40]  C. Naus Gap junctions and tumour progression. , 2002, Canadian journal of physiology and pharmacology.

[41]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[42]  H. Yamasaki,et al.  Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted. , 2000, The Journal of investigative dermatology.

[43]  V. Krutovskikh,et al.  Role of connexin (gap junction) genes in cell growth control and carcinogenesis. , 1999, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[44]  M. Rook,et al.  Identification of connexin43 as a functional target for Wnt signalling. , 1998, Journal of cell science.

[45]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[46]  G. Yang,et al.  Characterization of xenobiotic-metabolizing enzymes and nitrosamine metabolism in the human esophagus. , 1998, Carcinogenesis.

[47]  J. Trosko,et al.  Localization and function of the connexin 43 gap‐junction protein in normal and various oncogene‐expressing rat liver epithelial cells , 1996, Molecular carcinogenesis.

[48]  N. Gilula,et al.  The Gap Junction Communication Channel , 1996, Cell.

[49]  B L Langille,et al.  Cardiac malformation in neonatal mice lacking connexin43. , 1995, Science.

[50]  K. Willecke,et al.  Negative growth control of HeLa cells by connexin genes: connexin species specificity. , 1995, Cancer research.

[51]  S. Amin,et al.  Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. , 1989, Carcinogenesis.

[52]  W. Loewenstein,et al.  Intercellular Communication and the Control of Tissue Growth: Lack of Communication between Cancer Cells , 1966, Nature.

[53]  A. Ben-Ze'ev,et al.  beta-Catenin signaling in biological control and cancer. , 2007, Journal of cellular biochemistry.

[54]  L. Aicher,et al.  Aberrant beta-catenin signaling in tuberous sclerosis. , 2005, The American journal of pathology.

[55]  L. Aicher,et al.  Molecular Pathogenesis of Genetic and Inherited Diseases Aberrant (cid:1) -Catenin Signaling in Tuberous Sclerosis , 2005 .

[56]  Randall T Moon,et al.  WNT and beta-catenin signalling: diseases and therapies. , 2004, Nature reviews. Genetics.

[57]  Kathleen R. Cho,et al.  Role of (cid:1) -Catenin/T-Cell Factor-Regulated Genes in Ovarian Endometrioid Adenocarcinomas , 2002 .

[58]  V. Krutovskikh,et al.  Connexin genes and cell growth control. , 1996, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[59]  M. Djordjevic,et al.  Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. , 1994, Journal of toxicology and environmental health.

[60]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.